2-chloro-3-cyclopropylquinoline | 85274-12-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-chloro-3-cyclopropylquinoline
• CAS: 85274-12-0
• 化学式: C₁₂H₁₀ClN
• 分子量: 203.671
• InChiKey: VLFAMTJCJGTLMR-UHFFFAOYSA-N

物化性质

• 沸点：
  315.5±30.0 °C(Predicted)
• 密度：
  1.299±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-甲胺乙硫醇盐酸盐 、 2-chloro-3-cyclopropylquinoline 在 草酸 作用下， 以 N-甲基乙酰胺 、 甲醇 、 乙酸乙酯 为溶剂， 生成 3-cyclopropyl-2-(2-dimethylaminoethylthio)quinoline hydrogen oxalate
  参考文献：
  名称：

  Quinoline derivatives which are 5-hydroxytryptamine antagonists

  摘要：

  该公式化合物为：##STR1## 其中A代表基团--(CH.sub.2).sub.2 --，可以带有一个或两个定义的取代基；R.sup.1代表(3-4C)烷基或环丙基基团，或者可能带有一个或两个定义的取代基的苯基基团，或者是五个或六个环原子的杂环芳基基团，可以选择性地带有一个(1-3C)烷基取代基；R.sup.2和R.sup.3代表氢或(1-2C)烷基基团，或者R.sup.2代表与A的两碳原子骨架中的一个碳原子相连的(2-4C)烷基基团，以便与相邻的氮原子一起形成吡咯啉基或哌啶基；R.sup.4和R.sup.5中的一个代表氢，另一个代表氢、卤素原子或(1-3C)烷基或(1-3C)烷氧基基团；以及它们的酸盐。制造这些化合物的方法。包括其中一种化合物和药用稀释剂或载体的药物组合物。这些化合物是5-羟色胺拮抗剂。

  公开号：

  US04435405A1
• 作为产物：
  描述：

  N-(2-(cyclopropylethynyl)phenyl)formamide 在 N,N-二异丙基乙胺 、 三氯氧磷 、 四丁基氯化铵 作用下， 以 二氯甲烷 为溶剂， 反应 15.0h， 以90%的产率得到2-chloro-3-cyclopropylquinoline
  参考文献：
  名称：

  Tetrabutylammonium chloride-triggered 6-endo cyclization of o-alkynylisocyanobenzenes: an efficient synthesis of 2-chloro-3-substituted quinolines

  摘要：

  A highly efficient one-pot synthesis of 2-chloro-3-substituted quinolines has been developed by tetrabutylammonium chloride-triggered 6-endo cyclization of o-alkynylisocyanobenzenes, which are generated in situ by dehydration of the corresponding N-(2-ethynylphenyl)formamides. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2009.09.096

文献信息

• Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogs
  作者：Thomas P. Blackburn、Barry Cox、Allen J. Guildford、David J. Le Count、Derek N. Middlemiss、Robert J. Pearce、Craig W. Thornber

  DOI：10.1021/jm00395a013

  日期：1987.12

  A series of 2-[(2-aminoethyl)thio]quinolines substituted at the 3-position with alkyl, aryl, or heteroaryl groups has been prepared in the search for novel and selective 5-HT2 antagonists. The affinity of the compounds for 5-HT1 receptor sites was measured by their ability to displace [3H]-5-HT from rat brain synaptosomes whereas the affinity for 5-HT2 receptor sites was measured by their ability to displace [3H]spiperone from synaptosomes prepared from rat brain cortex. The 5-HT2 antagonist properties of the compounds were measured in vivo by their antagonism of 5-hydroxytryptophan-induced head twitches in the mouse and by their antagonism of hyperthermia induced by fenfluramine (N-ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine hydrochloride) in the rat. The structure-activity relationships in this series are discussed and the properties of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline hydrochloride (70) are highlighted.
• Quinoline derivatives
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0066993B1

  公开（公告）日：1985-01-30
• US4435405A
  申请人：——

  公开号：US4435405A

  公开（公告）日：1984-03-06
• Tetrabutylammonium chloride-triggered 6-endo cyclization of o-alkynylisocyanobenzenes: an efficient synthesis of 2-chloro-3-substituted quinolines
  作者：Lanying Liu、Yong Wang、Honggen Wang、Changlan Peng、Jiaji Zhao、Qiang Zhu

  DOI：10.1016/j.tetlet.2009.09.096

  日期：2009.12

  A highly efficient one-pot synthesis of 2-chloro-3-substituted quinolines has been developed by tetrabutylammonium chloride-triggered 6-endo cyclization of o-alkynylisocyanobenzenes, which are generated in situ by dehydration of the corresponding N-(2-ethynylphenyl)formamides. (C) 2009 Elsevier Ltd. All rights reserved.
• Quinoline derivatives which are 5-hydroxytryptamine antagonists
  申请人：Imperial Chemical Industries PLC

  公开号：US04435405A1

  公开（公告）日：1984-03-06

  Compounds of the formula: ##STR1## wherein A stands for the radical --(CH.sub.2).sub.2 -- which may bear one or two defined substituents; R.sup.1 stands for a (3-4C) alkyl or cyclopropyl radical, or a phenyl radical which may optionally bear one or two defined substituents, or a heteroaryl radical of five or six ring atoms which may optionally bear a (1-3C)alkyl substituent; R.sup.2 and R.sup.3 stand for hydrogen or a (1-2C)alkyl radical, or R.sup.2 stands for a (2-4C)alkylene radical which is linked to one of the carbon atoms forming the two-carbon-atom-backbone of A so as to form, together with the adjacent nitrogen atom, a pyrrolidinyl or piperidyl radical; and one of R.sup.4 and R.sup.5 stands for hydrogen, and the other stands for hydrogen, a halogen atom or a (1-3C)alkyl or (1-3C)alkoxy radical; and acid-addition salts thereof. Processes for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or carrier. The compounds are 5-hydroxytryptamine antagonists.

  该公式化合物为：##STR1## 其中A代表基团--(CH.sub.2).sub.2 --，可以带有一个或两个定义的取代基；R.sup.1代表(3-4C)烷基或环丙基基团，或者可能带有一个或两个定义的取代基的苯基基团，或者是五个或六个环原子的杂环芳基基团，可以选择性地带有一个(1-3C)烷基取代基；R.sup.2和R.sup.3代表氢或(1-2C)烷基基团，或者R.sup.2代表与A的两碳原子骨架中的一个碳原子相连的(2-4C)烷基基团，以便与相邻的氮原子一起形成吡咯啉基或哌啶基；R.sup.4和R.sup.5中的一个代表氢，另一个代表氢、卤素原子或(1-3C)烷基或(1-3C)烷氧基基团；以及它们的酸盐。制造这些化合物的方法。包括其中一种化合物和药用稀释剂或载体的药物组合物。这些化合物是5-羟色胺拮抗剂。